BioNexus Gene Lab Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	11	8	14	30	20	3	2
Market Cap Growth	-	-38.54%	-54.96%	54.07%	568.46%	30.20%	-
Enterprise Value	2	3	12	28	17	2	1
PE Ratio	7.61	-3.20	-38.46	40.44	18.03	-11.97	85.68
PS Ratio	1.12	0.86	1.25	2.27	1.73	23.24	10.67
PB Ratio	1.13	0.87	2.05	4.23	2.96	2.63	1.49
P/FCF Ratio	-6.45	-5.80	27.95	5066.05	150.51	-12.83	-7.22
P/OCF Ratio	-7.19	-6.46	25.16	3317.46	35.69	-13.58	-8.27
EV/Sales Ratio	0.19	0.27	1.06	2.12	1.50	17.18	5.13
EV/EBITDA Ratio	-1.44	-1.05	-62.59	24.35	12.40	-9.81	10.83
EV/EBIT Ratio	-1.38	-1.01	-39.93	26.85	13.39	-7.91	18.17
EV/FCF Ratio	-2.46	-1.80	23.74	4724.83	130.18	-9.48	-3.47
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.08	0.05
Debt / EBITDA Ratio	-0.05	-0.05	-0.31	0.07	0.09	-0.40	0.82
Debt / FCF Ratio	-0.09	-0.09	0.12	12.83	0.94	-0.39	-0.26
Quick Ratio	6.26	6.26	3.27	3.05	2.64	26.53	20.40
Current Ratio	4.93	4.93	3.00	3.07	2.37	17.11	20.64
Asset Turnover	1.04	0.86	1.25	1.40	1.13	0.10	0.13
Interest Coverage	61.37	-186.20	-23.33	81.39	112.60	0	0
Return on Equity (ROE)	-27.22%	-27.22%	-5.34%	10.47%	16.42%	-21.96%	1.74%
Return on Assets (ROA)	-23.06%	-23.06%	-4.07%	7.85%	10.82%	-20.02%	1.60%
Return on Capital (ROIC)	-26.49%	-26.49%	-4.33%	10.49%	16.27%	-22.75%	1.65%
Earnings Yield	-24.05%	-31.25%	-2.60%	2.47%	5.55%	-8.35%	1.17%
FCF Yield	-13.27%	-17.25%	3.58%	0.02%	0.66%	-7.80%	-13.84%
Buyback Yield / Dilution	-22.04%	-10.17%	-0.99%	-66.36%	-19.16%	-30.20%	-
Total Shareholder Return	-22.04%	-10.17%	-0.99%	-66.36%	-19.16%	-30.20%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.